4
Changes in Ownership
Monopar Therapeutics Filed Acc 0001437749-25-037171
Options or other derivatives
- Chief Operating Officer acquired 22,888 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Cittadine Andrew · Chief Operating Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-02 | Grant or award : show line 1 in the form Stock Options | +8,969 | 8,969 | D |
| 2025-12-02 | Grant or award : show line 2 in the form Restricted Stock Units | +13,919 | 52,593 | D |
Loading xslF345X05/rdgdoc.xml…